HomeEXEL • NASDAQ
Exelixis Inc
add
In the news
Previous close
$38.49
Day range
$37.83 - $38.78
Year range
$25.12 - $49.40
Market cap
10.36B USD
Avg Volume
3.58M
P/E ratio
18.45
Dividend yield
-
Primary exchange
NASDAQ
About
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer. Wikipedia
Founded
Nov 15, 1994
Headquarters
Website
Employees
1,147